Igf-1 des is a peptide that is secreted by the liver of animal test subjects. Its structure consists of 67 amino acids and contains highly anabolic structure that is naturally released in order to stimulate hormones. The peptide is secreted by the liver.
Igf-1 des’s Operational Mechanics
According to scientific study that has been conducted on animal test subjects, Igf-1 des’s main operational function is to create a process known as hyperplasia. Also known as hypergenesis, this process describes the control and regulation of cellular proliferation. This process is triggered by a host of causes, including:
- Chronic inflammatory response – The call for the proliferation of cells in order to help fight off inflammation throughout various bodily areas.
- Hormonal Dysfunction – The need to generate cells to assist in warding off various forms of ailments which may cause the endocrine system to function improperly.
- Increased demand – The need for cells to steady an area where cellular proliferation is necessary, such as the creation of a base layer of epidermis in order to make up for skin loss.
- Other forms of bodily compensation – This could include the loss of cells due to disease or damage to various regions of the body.
Because of Igf-1 des’s ability to produce hyperplasia, scientific research based on animal test subjects builds its study on the peptide relating to its ability to control the cell proliferation and tissue development. This study ranges from its effects on the skeletal and muscular growth on animal test subjects as well as the effects it may have on neurological growth. Studies have shown that the peptide does have the aptitude to influence neuronal functionality and structure throughout its life span. It has also shown a facility to preserve nerve cell function and promote nerve growth.
Igf-1 des’s Theoretical Benefits
Scientific research conducted on animal test subjects has determined several theoretical benefits in relation to the peptide. Some of these positive benefits include:
- Accelerated rate of injury recovery. Scientific study based on animal test subjects has determined that the peptide’s capability to promote cellular proliferation can cause an increased amount of cells to be created in times when a subject suffers an injury. This proliferation, in turn, will allow for a much faster rate of healing.
- Accelerated rate of muscle repair. Because of Igf-1 des’s mechanics and its ability to promote hyperplasia, scientific study based on animal test subjects have determined that the peptide can increase the type of cellular proliferation that is required to repair muscular tissue. This then can lead to an increase in muscular growth. (Visit www.maximpeptide.com for more information on Igf Des)
- Slowing the aging process. Scientific study based on research that has been conducted on laboratory rats has determined that Igf-1 des’s promotion of cellular production decelerated the natural breaking down of the muscle fibers that control elasticity and flexibility in the skin and muscles. This enabled middle-aged and older rats to maintain a level of speed and power that was on par with the capability of younger rats.
Igf-1 des’s Negative Side Effects
Even though scientific research conducted on animal test subjects has determined that there are several theoretical positive benefits regarding Igf-1 des, it should be noted that the studies have also determined a few negative side effects in relation to the peptide. These side effects include:
- Swelling – This condition has a tendency to happen in the extremities of animal test subjects.
- Heart Irregularities – These conditions include heart arrhythmia and severe ailments like cardiac arrest.
- Development of hypoglycemia – This condition involves an abnormally depleted amount of glucose found in the blood. Currently, this side effect is determined to only be a potential result of higher doses.
- Drop in blood pressure.
This scientific research on animal test subjects has determined that the number of negative side effects is lower in occurrence when compared to the amount of theoretical benefits that have been associated with Igf-1 des.
For Scientific Use Only
While scientific study has been conducted on animal test subjects to gauge Igf-1 des’s range of operational mechanics and functionality as well as its theoretical benefits and negative side effects, it should be noted that any findings related to the peptide are still based in current laboratory research. Because Igf-1 des is currently in the research phase, any usage or study relating to the effects, benefits, and side effects of the peptide should exclusively be held to the restrictions of a strictly controlled environment such as a laboratory or a medical research facility.